Karl‐F. Bergeron

2.5k total citations
28 papers, 983 citations indexed

About

Karl‐F. Bergeron is a scholar working on Surgery, Molecular Biology and Biochemistry. According to data from OpenAlex, Karl‐F. Bergeron has authored 28 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Molecular Biology and 6 papers in Biochemistry. Recurrent topics in Karl‐F. Bergeron's work include Congenital gastrointestinal and neural anomalies (7 papers), Lipid metabolism and biosynthesis (5 papers) and Intestinal Malrotation and Obstruction Disorders (5 papers). Karl‐F. Bergeron is often cited by papers focused on Congenital gastrointestinal and neural anomalies (7 papers), Lipid metabolism and biosynthesis (5 papers) and Intestinal Malrotation and Obstruction Disorders (5 papers). Karl‐F. Bergeron collaborates with scholars based in Canada, United States and Mexico. Karl‐F. Bergeron's co-authors include Cathérine Mounier, Nicolas Pilon, Bruce P. Brandhorst, Éric Rassart, Antony D. Karelis, Richard O. Hynes, Robert D. Burke, Charles A. Whittaker, James R. Whittle and James M. Ntambi and has published in prestigious journals such as Journal of Clinical Investigation, Langmuir and The FASEB Journal.

In The Last Decade

Karl‐F. Bergeron

28 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl‐F. Bergeron Canada 18 391 187 183 123 121 28 983
Izabella Klein Hungary 12 426 1.1× 102 0.5× 260 1.4× 82 0.7× 95 0.8× 21 972
Jong‐Gil Park South Korea 19 649 1.7× 205 1.1× 227 1.2× 332 2.7× 74 0.6× 61 1.5k
Heather A. Hostetler United States 19 831 2.1× 211 1.1× 153 0.8× 250 2.0× 72 0.6× 32 1.2k
Jianqiang Mao United States 16 557 1.4× 158 0.8× 130 0.7× 177 1.4× 54 0.4× 20 1.1k
Ryosei Sakai Japan 21 675 1.7× 269 1.4× 91 0.5× 97 0.8× 118 1.0× 46 1.2k
Damir Zadravec Sweden 6 440 1.1× 166 0.9× 77 0.4× 102 0.8× 242 2.0× 7 953
Mario Ruiz Sweden 17 347 0.9× 147 0.8× 94 0.5× 98 0.8× 43 0.4× 27 726
Jean Z. Lin United States 14 363 0.9× 284 1.5× 103 0.6× 190 1.5× 40 0.3× 18 931
Youqing Xu China 18 348 0.9× 185 1.0× 132 0.7× 442 3.6× 70 0.6× 59 1.3k
Félix López Spain 14 360 0.9× 115 0.6× 283 1.5× 98 0.8× 103 0.9× 29 1.2k

Countries citing papers authored by Karl‐F. Bergeron

Since Specialization
Citations

This map shows the geographic impact of Karl‐F. Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl‐F. Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl‐F. Bergeron more than expected).

Fields of papers citing papers by Karl‐F. Bergeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl‐F. Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl‐F. Bergeron. The network helps show where Karl‐F. Bergeron may publish in the future.

Co-authorship network of co-authors of Karl‐F. Bergeron

This figure shows the co-authorship network connecting the top 25 collaborators of Karl‐F. Bergeron. A scholar is included among the top collaborators of Karl‐F. Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl‐F. Bergeron. Karl‐F. Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergeron, Karl‐F., Francis Bergeron, Xiang Zhou, et al.. (2025). Brain‐Specific Gata4 Downregulation in Greywick Female Mice Models the Metabolic Subtype of Polycystic Ovary Syndrome. The FASEB Journal. 39(12). e70717–e70717. 1 indexed citations
2.
Guo, Zhiqiang, Karl‐F. Bergeron, & Cathérine Mounier. (2024). Oleate Promotes Triple-Negative Breast Cancer Cell Migration by Enhancing Filopodia Formation through a PLD/Cdc42-Dependent Pathway. International Journal of Molecular Sciences. 25(7). 3956–3956. 1 indexed citations
3.
Guo, Zhiqiang, et al.. (2023). Unveiling the MUFA–Cancer Connection: Insights from Endogenous and Exogenous Perspectives. International Journal of Molecular Sciences. 24(12). 9921–9921. 12 indexed citations
4.
Bergeron, Karl‐F., et al.. (2020). SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line. Breast Cancer. 27(4). 594–606. 27 indexed citations
5.
Tsering, Thupten, Anas Alazzam, Karl‐F. Bergeron, et al.. (2020). The effect of different organic solvents in liposome properties produced in a periodic disturbance mixer: Transcutol®, a potential organic solvent replacement. Colloids and Surfaces B Biointerfaces. 198. 111447–111447. 26 indexed citations
6.
7.
Rassart, Éric, et al.. (2020). Apolipoprotein D. Gene. 756. 144874–144874. 68 indexed citations
8.
Bergeron, Karl‐F., et al.. (2019). A high-fat diet enriched in medium chain triglycerides triggers hepatic thermogenesis and improves metabolic health in lean and obese mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(3). 158582–158582. 45 indexed citations
9.
Bergeron, Karl‐F., et al.. (2019). Apolipoprotein D overexpression alters hepatic prostaglandin and omega fatty acid metabolism during the development of a non-inflammatory hepatic steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864(4). 522–531. 9 indexed citations
10.
Bergeron, Karl‐F., Michel Lacaille, Isabelle Lemieux, et al.. (2018). High ApoD protein level in the round ligament fat depot of severely obese women is associated with an improved inflammatory profile. Endocrine. 61(2). 248–257. 24 indexed citations
11.
12.
Bergeron, Karl‐F., et al.. (2017). Reduced SCD1 activity alters markers of fatty acid reesterification, glyceroneogenesis, and lipolysis in murine white adipose tissue and 3T3-L1 adipocytes. American Journal of Physiology-Cell Physiology. 313(3). C295–C304. 26 indexed citations
13.
Escoula, Quentin, et al.. (2016). SCD1 deficiency protects mice against ethanol-induced liver injury. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(11). 1662–1670. 33 indexed citations
14.
Bergeron, Karl‐F., et al.. (2016). Hepatic BSCL2 (Seipin) Deficiency Disrupts Lipid Droplet Homeostasis and Increases Lipid Metabolism via SCD1 Activity. Lipids. 52(2). 129–150. 26 indexed citations
15.
Karelis, Antony D., et al.. (2016). Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals. Nutrients. 8(5). 281–281. 91 indexed citations
16.
Bergeron, Karl‐F., et al.. (2016). Upregulation of the Nr2f1-A830082K12Rik gene pair in murine neural crest cells results in a complex phenotype reminiscent of Waardenburg syndrome type 4. Disease Models & Mechanisms. 9(11). 1283–1293. 30 indexed citations
17.
Bergeron, Karl‐F., et al.. (2015). Male-Biased Aganglionic Megacolon in the TashT Mouse Line Due to Perturbation of Silencer Elements in a Large Gene Desert of Chromosome 10. PLoS Genetics. 11(3). e1005093–e1005093. 28 indexed citations
18.
Bergeron, Karl‐F., et al.. (2013). A Quantitative Cell Migration Assay for Murine Enteric Neural Progenitors. Journal of Visualized Experiments. e50709–e50709. 4 indexed citations
19.
Bergeron, Karl‐F., Xing Xu, & Bruce P. Brandhorst. (2010). Oral–aboral patterning and gastrulation of sea urchin embryos depend on sulfated glycosaminoglycans. Mechanisms of Development. 128(1-2). 71–89. 22 indexed citations
20.
Whittaker, Charles A., Karl‐F. Bergeron, James R. Whittle, et al.. (2006). The echinoderm adhesome. Developmental Biology. 300(1). 252–266. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Izabella Klein Breakdown of academic impact, for papers by Jong‐Gil Park Breakdown of academic impact, for papers by Heather A. Hostetler Breakdown of academic impact, for papers by Jianqiang Mao Breakdown of academic impact, for papers by Ryosei Sakai Breakdown of academic impact, for papers by Damir Zadravec Breakdown of academic impact, for papers by Mario Ruiz Breakdown of academic impact, for papers by Jean Z. Lin Breakdown of academic impact, for papers by Youqing Xu Breakdown of academic impact, for papers by Félix López
Rankless by CCL
2026